Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
| Revenue (Most Recent Fiscal Year) | $1.16B |
| Net Income (Most Recent Fiscal Year) | $168.10M |
| PE Ratio (Current Year Earnings Estimate) | 42.98 |
| PE Ratio (Trailing 12 Months) | 44.35 |
| PEG Ratio (Long Term Growth Estimate) | 5.33 |
| Price to Sales Ratio (Trailing 12 Months) | 9.80 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.36 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 31.24 |
| Pre-Tax Margin (Trailing 12 Months) | 15.05% |
| Net Margin (Trailing 12 Months) | 12.86% |
| Return on Equity (Trailing 12 Months) | 12.76% |
| Return on Assets (Trailing 12 Months) | 9.59% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.56 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.26 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.14 |
| Inventory Turnover (Trailing 12 Months) | 2.23 |
| Book Value per Share (Most Recent Fiscal Quarter) | $13.13 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.37 |
| Earnings per Share (Most Recent Fiscal Year) | $1.57 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.94 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 158.89M |
| Free Float | 152.69M |
| Market Capitalization | $11.49B |
| Average Volume (Last 20 Days) | 0.66M |
| Beta (Past 60 Months) | 1.27 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 98.95% |
| Annual Dividend (Based on Last Quarter) | $0.32 |
| Dividend Yield (Based on Last Quarter) | 0.44% |